Skip to main content

Table 2 Genes in the copy number-variable regions (CNVRs) are associated with disease and disease susceptibility

From: A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan

CNVR ID

Chr

Position (bp)

Variant Type

# of observationsb

Gene symbolc

Diseased

1a

1

17313441–19641958

Gain

4

ALDH4A1

Hyperprolinemia, type II

     

MRT4

Mental retardation

     

PAX7

Rhabdomyosarcoma, alveolar

13a

1

229469402–229804452

Loss

11

EGLN1

Erythrocytosis, familial, 3

     

GNPAT

Chondrodysplasia punctata, rhizomelic, type 2

31a

3

15281603–15545420

Gain

8

COLQ

Endplate acetylcholinesterase deficiency

38

3

130171189–130741211

Loss

2

GP9

Bernard-Soulier syndrome, type C

     

RHO

Retinitis pigmentosa 4

40a

3

166493869–167384443

Loss

4

BCHE

Apnea, postanesthetic

80

5

147335938–147460716

Loss

2

SPINK5

Atopy

111

7

80115926–80209630

Loss

10

CD36

Platelet glycoprotein IV deficiency

120a

7

142035481–142155613

Loss

2

PRSS1

Trypsinogen deficiency

121a

7

154254541–155708987

Gain

6

SHH

Coloboma, ocular

124a

8

13016678–13270959

Loss and Gain

4

DLC1

Colorectal cancer

147

9

103072622–103206674

Loss

3

BAAT

Hypercholanemia, familial

149a

9

134892783–137859477

Gain

8

ADAMTS13

Thrombotic thrombocytopenic purpura, familial

     

CEL

Maturity-onset diabetes of the young, type VIII

     

COL5A1

Ehlers-Danlos syndrome, type I

     

DBH

Dopamine beta-hydroxylase deficiency

     

SURF1

Leigh syndrome, due to COX deficiency

152a

10

49832039–50706976

Gain

5

CHAT

Myasthenic syndrome, congenital, associated with episodic apnea

     

ERCC6

Cerebrooculofacioskeletal syndrome 1

156a

10

125651321–126729328

Loss

2

OAT

Gyrate atrophy of choroid and retina with ornithinemia

163a

12

2449181–3410784

Gain

6

CACNA1C

Timothy syndrome

164

12

4794562–5039110

Gain

3

KCNA1

Episodic ataxia/myokymia syndrome

167a

12

21603812–21931308

Loss

8

ABCC9

Cardiomyopathy, dilated, 1O

     

GYS2

Glycogen storage disease, type 0

     

KCNJ8

Prinzmetal angina

     

LDHB

Lactate dehydrogenase-B deficiency

176a

13

22656237–23918863

Gain

2

SACS

Spastic ataxia, Charlevoix-Saguenay type

     

SGCG

Muscular dystrophy, limb-girdle, type 2C

206

16

11215600–11869359

Loss

4

LITAF

Charcot-Marie-Tooth disease, type 1C

212a

17

72497067–78181864

Gain

5

ACTG1

Deafness, autosomal dominant 20/26

     

ASPSCR1

Alveolar soft-part sarcoma

     

FSCN2

Retinitis pigmentosa-30

     

GAA

Glycogen storage disease II

     

SGSH

Sanfilippo syndrome, type A

     

SOCS3

Dermatitis, atopic, 4

215a

18

26241506–27419753

Loss

5

DSC2

Arrhythmogenic right ventricular dysplasia, familial, 11

     

DSG1

Keratosis palmoplantaris striata I

     

DSG2

Arrhythmogenic right ventricular dysplasia, familial, 10

     

DSG4

Hypotrichosis, localized, autosomal recessive

217a

18

51204895–51803567

Loss

4

TCF4

Pitt-Hopkins syndrome

230a

22

47187524–49023156

Gain

4

ALG12

Congenital disorder of glycosylation, type Ig

     

MLC1

Megalencephalic leukoencephalopathy with subcortical cysts

  1. aCNVRs reported in the database of genomic variants.
  2. bTotal number of gains and losses observed for a CNVR.
  3. cGene overlapping a CNVR based on ReqSeq of the UCSC March 2006 assembly.
  4. dDisease or disease susceptibility associated with the gene, according to the OMIM Morbid Map.